An interaction between human colon carcinoma cells and hepatocytes activates transforming growth factor-β1 in vitro

Cancer Letters

Volumn 142, Issue 1, 1999, Pages 83-89

  Nishibori, Hideki ^a   Watanabe, Masahiko ^a   Narai, Shin ^a   Kubota, Tetsuro ^a   Matsubara, Chitose ^a   Teramoto, Tatsuo ^a   Kitajima, Masaki ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Activation; Co culture; Colon carcinoma; Hepatocyte; Transforming growth factor 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CARCINOGENESIS; CELL INTERACTION; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; PRIORITY JOURNAL;

CARCINOMA; CELL COMMUNICATION; COCULTURE TECHNIQUES; COLONIC NEOPLASMS; HUMANS; LIVER; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0032974162     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00152-4     Document Type: Article

References (24)

1. Nicolson G.L. Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev. 7:1988;143-188.
2. Paget S. The distribution of secondary growths in cancer of the breast. Lancet. 1:1889;571-573.
3. Gutman M., Fidler I.J. Biology of human colon cancer metastasis. World J. Surg. 19:1995;226-234.
4. Kuo T.H., Kubota T., Watanabe M., Furukawa T., Teramoto T., Ishibiki K., Kitajima M., Moossa A.R., Penman S., Hoffman R.M. Liver colonization competence governs colon cancer metastasis. Proc. Natl. Acad. Sci. USA. 92:1995;12085-12089.
5. 3H] thymidine incorporation assay. J. Immunol. Methods. 170:1994;211-224.
6. Russel W.E., Coffey R.J. Jr, Ouellette A.J., Moses H.L. Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc. Natl. Acad. Sci. USA. 85:1988;5126-5130.
7. Massagué J. The transforming growth factor-β family. Annu. Rev. Cell Biol. 6:1990;597-641.
8. Taipale J., Saharinen J., Keski-Oja J. Extracellular matrix-associated transforming growth factor-β: role in cancer cell growth and invasion. Adv. Cancer Res. 75:1998;87-134.
9. Miyazono K., Olofsson A., Colosetti P., Heldin C.H. A role of the latent TGF-β1-binding protein in the assembly and secretion of TGF-β1. EMBO J. 10:1991;1091-1101.
10. Lyons R.M., Keski-Oja J., Moses H.L. Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium. J. Cell Biol. 106:1988;1659-1665.
11. Lyons R.M., Gentry L.E., Purchio A.F., Moses H.L. Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin. J. Cell Biol. 110:1990;1361-1367.
12. Miyazono K., Heldin C.H. Role of carbohydrate structures in TGF-β1 latency. Nature. 338:1989;158-160.
13. Sato Y., Okada F., Abe M., Seguchi T., Kuwano M., Sato S., Furuya A., Hanai N., Tamaoki T. The mechanism for the activation of latent TGF-β during co-culture of endothelial cells and smooth muscle cells: cell-type specific targeting of latent TGF-β to smooth muscle cells. J. Cell Biol. 123:1993;1249-1254.
14. Schultz-Cherry S., Murphy-Ullrich J.E. Thrombospondn causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism. J. Cell Biol. 122:1993;923-932.
15. Crawford S.E., Stellmach V., Murphy-Ullrich J.E., Ribeiro S.M.F., Lawler J., Hynes R.O., Boivin G.P., Bouck N. Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell. 93:1998;1159-1170.
16. Munger J.S., Huang X., Kawakatsu H., Griffiths M.J.D., Dalton S.L., Wu J., Pittet J.F., Kaminski N., Garat C., Matthay M.A., Rifkin D.B., Sheppard D. The integrin αvβ6 binds and activates latent TGF-β1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 96:1999;319-328.
17. Mooradian D.L., McCarthy J.B., Komanduri K.V., Furcht L.T. Effects of transforming growth factor-β1 on human pulmonary adenocarcinoma cell adhesion, motility, and invasion in vitro. J. Natl. Cancer Inst. 84:1992;523-527.
18. Ueki N., Ohkawa T., Yokoyama Y., Maeda J., Kawai Y., Ikeda T., Amuro Y., Hada T., Higashino K. Potentiation of metastatic capacity by transforming growth factor-β1 gene transfection. Jpn. J. Cancer Res. 84:1993;589-593.
19. Benefield J., Petruzzelli G.J., Fowler S., Taitz A., Kallanis J., Young M.R. Regulation of the steps of angiogenesis by human head and neck squamous cell carcinoma. Invasion Metastasis. 16:1996;291-301.
20. Fakhrai H., Dorigo O., Shawler D.L., Lin H., Mercola D., Black K.L., Royston I., Sobol R.E. Eradication of established intracranial rat gliomas by transforming growth factor β antisense gene therapy. Proc. Natl. Acad. Sci. USA. 93:1996;2909-2914.
21. Welch D.R., Fabra A., Nakajima M. Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc. Natl. Acad. Sci. USA. 87:1990;7678-7682.
22. Shimizu S., Nishikawa Y., Kuroda K., Takagi S., Kozaki K., Hyuga S., Saga S., Matsuyama M. Involvement of transforming growth factor β1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells. Cancer Res. 56:1996;3366-3370.
23. Dalal B.I., Keown P.A., Greenberg A.H. Immunocytochemical localization of secreted transforming growth factor-β1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma. Am. J. Pathol. 143:1993;381-389.
24. Picon A., Gold L.I., Wang J., Cohen A., Friedman E. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor β1. Cancer Epidemiol. Biomarkers Prev. 7:1998;497-504.